TrovaGene (TROV) PT Lowered to $6 at Maxim Group Jul 31, 2019 08:27AM
Maxim Group Upgrades TrovaGene (TROV) to Buy Jun 15, 2018 02:09PM
Maxim Group Downgrades TrovaGene (TROV) to Hold; Capital Raise Needed Nov 10, 2017 07:40AM
Trovagene (TROV) Reports $7.1M Direct Offering of Common Stock, Warrants Jul 14, 2017 09:02AM
Trovagene Announces $7.1 Million Registered Direct Offering Jul 14, 2017 09:00AM


Jun 12, 2017 10:55AM Maxim Group Reiterates Buy Rating & $4 PT on Trovagene (TROV); 'AstraZeneca (AZN) On Board to Use Trovera'
Apr 12, 2017 12:30PM Maxim Group Upgrades TrovaGene (TROV) to Buy
Mar 16, 2017 09:38AM Trovagene (TROV) Down 20% Following Q4 EPS Miss, Multiple Downgrades
Mar 16, 2017 07:31AM Maxim Group Downgrades TrovaGene (TROV) to Hold
Jul 6, 2016 04:04PM Maxim Group Starts TrovaGene (TROV) at Buy, $12 PT
Jul 22, 2015 10:12AM Trovagene, Inc. Announces Closing of Public Offering of Common Stock
Jul 17, 2015 09:03AM Trovagene (TROV) Prices 4M Common Stock Offering for Proceeds of $35M
Jul 17, 2015 09:00AM Trovagene, Inc. Announces Pricing of Public Offering of Common Stock
Feb 6, 2015 08:29AM Trovagene (TROV) Prices 4.44M Common Offering for Proceeds of ~$20M
Jul 9, 2014 05:39PM Maxim Group Starts TrovaGene (TROV) at Buy